Northpond Ventures

The record

Every round we can evidence, newest first45 appearances

1. 2026

   4 rounds

2. Oct
   OMass TherapeuticsSeries C · GB · Jefferson Life Sciences$310MWith 12 others
3. Sept
   Transition BioGrant · US$750KSole investor
4. Jan
   VieCureGrowth · US · Socium Ventures$43MLed
5. Jan
   VizgenSeries E · US$48MWith 1 other
6. 2025

   5 rounds

7. Nov
   ElephasVenture · US$40MWith 2 others
8. May
   QbDVisionSeries A · US$13MWith 2 others
9. May
   Outcomes4MeSeries A · US$21MWith 2 others
10. Feb
    EnPlusOne BiosciencesVenture · US$10MWith 1 other
11. Feb
    OPT IndustriesVenture · USUndisclosedWith 3 others
12. 2024

    6 rounds

13. Oct
    Transition BioVenture · US$13MSole investor
14. Sept
    InflammatixSeries E · US$57MWith 2 others
15. Aug
    KytopenGrant · US$1.6MWith 2 others
16. Jul
    UltivueVenture · US$3.3MWith 2 others
17. Apr
    SeLux DiagnosticsSeries D · US$48MWith 3 others
18. Apr
    Slingshot BiosciencesSeries A · US$15MWith 1 other
19. 2023

    7 rounds

20. Dec
    Totus MedicinesSeries B · US$66MWith 1 other
21. Nov
    Aro BiotherapeuticsSeries B · US$42MSole investor
22. Nov
    ScitaraSeries B · US$15MWith 1 other
23. Nov
    ScitaraSeries B · US$8.5MWith 1 other
24. May
    Telesis BioUS$74MSole investor
25. May
    OMass TherapeuticsSeries B · GB$13MWith 3 others
26. Feb
    Faro AISeries A · US$20MWith 4 others
27. 2022

    8 rounds

28. Nov
    Opna BioSeries A · CH$38MWith 2 others
29. Sept
    Isolere BioGrant · US$75KWith 3 others
30. Jun
    Code BiotherapeuticsSeries A · US$75MWith 2 others
31. Mar
    Triumvira ImmunologicsSeries A · US$45MWith 1 other
32. Mar
    Nanoview BiosciencesDebt · US$2.5MWith 3 others
33. Feb
    Walking Fish TherapeuticsSeries A · US$23MWith 1 other
34. Feb
    Story HealthSeries A · US$23MWith 3 others
35. Feb
    1859Series A · US$40MWith 1 other
36. 2021

    4 rounds

37. Oct
    SimBioSysSeries A · US$15MWith 1 other
38. Sept
    KytopenSeries A · US · Firms' own news pages$30MLed
39. Aug
    Vigil NeuroscienceSeries B · US · Hatteras Venture Partners$90MWith 12 others
40. Jun
    Hawthorne EffectSeries A$20MWith 2 others
41. 2020

    2 rounds

42. Nov
    ArtisanBioSeries A$21MWith 1 other
43. Nov
    RefeynSeries A$30MWith 2 others
44. 2019

    8 rounds

45. Dec
    ChromaCodeSeries C · US · FinSMEs$28MLed
46. Sept
    SGI-DNASeries A · US · FinSMEs$25MLed
47. Aug
    SpeeDxAU · FinSMEs$100MSole investor
48. May
    IsoPlexisSeries C · US · FinSMEs$25MLed

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

We also hold 18 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.